emetogenic

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
aprepitant chemotherapy-induced emesis Emend ondansetron hydrochloride	Palonosetron has been available internationally after being registered in the USA in 2003, and is indicated for the prevention of acute nausea and vomiting associated with highly emetogenic chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy. Helsinn Announces License Agreement With Specialised Therapeutics for ... by PR Newswire Europe Hence we have performed a double blind, randomized controlled trial to compare the relative efficacies of ondansetron, granisetron and palonosetron for both acute and delayed onset emesis, in moderately and highly emetogenic chemotherapy against their respective prices in Indian market. Comparing different antiemetic regimens for chemotherapy induced ... by Ghosh, Sayantani; Dey, Saugat / International Journal of Collaborative Research on Internal Medicine & Public Health (IJCRIMPH) Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the ESMO (European Society of Medical Oncology) Symposium on Cancer and Nutrition in Zurich shows that palonosetron, a second generation 5-HT3 receptor antagonist, warrants adequate caloric intake in oncology patients receiving high emetogenic chemotherapy (HEC). Palonosetron Warrants Adequate Caloric Intake in Oncology Patients ... by PR Newswire	Emergency Privileges emergency psychiatric commitment emergency readiness emergency room emergency services Emergency Surgery emergency theory Emergency Use emergent Emergent Disease emergent evolution emerging infection emerging pathogen emeritus staff emery Emery-Dreifuss muscular dystrophy Emery-Dreifuss syndrome emesis emesis basin emesis gravidarum Emete-con emetic emetine emetine hydrochloride emetocathartic emetogenic Emetophobia Emetrol Emex australis EMF EMG EMG syndrome emia, -aemia emic emiction emigration Emilia sonchifolia eminence eminence, retromylohyoid eminenectomy eminentia emiocytosis emissarium emissary emissary vein emissary veins emission emission computed tomography emit EMLA EMMA	emesis basin emesis gravidarum Emet Emete-con EMETF emetic emetic emetic emetic emetic center emetic center emetic center emetic center emetic factor emetic factor emetic factor Emetic powder Emetical emetically emetically emetically Emetics Emetics Emetics emetine emetine emetine emetine hydrochloride Emeto-cathartic emetocathartic emetogenic Emetology Emetology Emetology Emetophobia EMETRA Emetrol Emetrol EMETT Emetteur Emeu Emeu Emeu Emeu Emeute Emevi Emevi EMEVS EMEWS Emex Emex australis EMEYF emf emf emf emf emf emf EMF File Format EMF Index EMF RAPID

Mentioned in

References in periodicals archive

Medical browser

Full browser

aprepitant
chemotherapy-induced emesis
Emend
ondansetron hydrochloride

Palonosetron has been available internationally after being registered in the USA in 2003, and is indicated for the prevention of acute nausea and vomiting associated with highly emetogenic chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.

Helsinn Announces License Agreement With Specialised Therapeutics for ... by PR Newswire Europe

Hence we have performed a double blind, randomized controlled trial to compare the relative efficacies of ondansetron, granisetron and palonosetron for both acute and delayed onset emesis, in moderately and highly emetogenic chemotherapy against their respective prices in Indian market.

Comparing different antiemetic regimens for chemotherapy induced ... by Ghosh, Sayantani; Dey, Saugat / International Journal of Collaborative Research on Internal Medicine & Public Health (IJCRIMPH)

Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the ESMO (European Society of Medical Oncology) Symposium on Cancer and Nutrition in Zurich shows that palonosetron, a second generation 5-HT3 receptor antagonist, warrants adequate caloric intake in oncology patients receiving high emetogenic chemotherapy (HEC).

Palonosetron Warrants Adequate Caloric Intake in Oncology Patients ... by PR Newswire